Antiviral Therapy Improves Survival Rates For Kidney Transplant Recipients With Hepatitis B Or C (IMAGE)

Elsevier

Antiviral Therapy Improves Survival Rates For Kidney Transplant Recipients With Hepatitis B Or C

Caption

10-year patient survival (left) and 10-year graft survival (right) in patients in the three groups: HBV-infected, HCV-infected, and non-infected.

Credit

Journal of Hepatology

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.